Generate Biomedicines
GENB----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Generate Biomedicines(GENB) predict that the Revenue is 7.224 M (--%), Beat estimate;the EBIT is -64.11 M (--%), Miss estimate;the EPS is -1.07 (--%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
0.01B--
0.00B--
+0.00B--%
EBITMiss expectations
-0.06B--
-0.06B--
-0.00B--%
EPSMiss expectations
-1.07--
-0.5225--
-0.5475--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf